Investors
Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
Key information
2022 First quarter results announcement
We announced our Q1 2022 results for the period which ended 31 March 2022 on Wednesday 27 April.
Latest information
Annual Report 2021
We published our Annual Report 2021 on 04 March 2022. View the summary and download the full report.
Latest press releases
- ViiV Healthcare commits to grant voluntary licence for patents relating to cabotegravir long-acting for PrEP to Medicines Patent Pool
- China approves Cervarix two-dose vaccine schedule for girls aged 9 to 14 against certain types of cancer-causing human papillomavirus
- GSK unveils latest research advances demonstrating strength of its portfolio and pipeline at ASCO and EHA
Sign up for announcements
Sign up to receive email notifications when we publish a stock exchange announcement.